Gamgee
YC S26Tampa, US · Founded 2026 · 2 employees · 1 known investors
GAMGEE develops personalised mRNA cancer vaccines for dogs, created from the animal's own tumour tissue to help its immune system fight the cancer. The company manages the full process end to end—from diagnosis and tissue sampling with the pet owner's vet, to genomic analysis and treatment delivery via veterinary oncologists—and is currently running clinical trials in Australia while accepting applications globally.
Also known as Gamgee Technologies
AI & Machine LearningBiotechDeep TechHealthtechGenomicsOncologyAIUnited States of AmericaAmerica / CanadaFully Remote
Founders & leadership· Y Combinator alumni (S26)
Gamgee was founded in 2026 by Paul Conyngham.
PC
Paul Conynghamin𝕏FounderPaul Conyngham co-founded Core Intelligence, which developed applied AI systems for startups and enterprise, and has worked on machine learning, data science, and electrical and computer systems engineering. He is founder of Gamgee Technologies, which develops personalized mRNA cancer vaccines.
RQ
Robert QuinnNamed on SEC filing
VK
Vinod KhoslaNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$4M disclosed across 1 round · 2014
▶$4MraisedNov 2014 · 3 investors · Other TechnologyRule 506(b)
▶$4MraisedNov 2014 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Robert QuinnExecutive Officer, Director, Promoter
- Vinod KhoslaDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Gamgee do?
- GAMGEE develops personalised mRNA cancer vaccines for dogs, created from the animal's own tumour tissue to help its immune system fight the cancer. The company manages the full process end to end—from diagnosis and tissue sampling with the pet owner's vet, to genomic analysis and treatment delivery via veterinary oncologists—and is currently running clinical trials in Australia while accepting applications globally.
- Who founded Gamgee?
- Gamgee was founded by Paul Conyngham in 2026.
- Who are Gamgee's investors?
- Gamgee's investors include Y Combinator.
- How much funding has Gamgee raised?
- Gamgee has disclosed $4M raised across 1 round.
- Where is Gamgee headquartered?
- Gamgee is headquartered in Tampa, US.